300138.SZ
Chenguang Biotech Group Co Ltd
Price:  
11.14 
CNY
Volume:  
10,031,583
China | Food Products

300138.SZ WACC - Weighted Average Cost of Capital

The WACC of Chenguang Biotech Group Co Ltd (300138.SZ) is 7.8%.

The Cost of Equity of Chenguang Biotech Group Co Ltd (300138.SZ) is 10.85%.
The Cost of Debt of Chenguang Biotech Group Co Ltd (300138.SZ) is 5%.

RangeSelected
Cost of equity8.8% - 12.9%10.85%
Tax rate12.6% - 13.8%13.2%
Cost of debt5.0% - 5.0%5%
WACC6.7% - 8.9%7.8%
WACC

300138.SZ WACC calculation

CategoryLowHigh
Long-term bond rate2.7%3.2%
Equity market risk premium6.1%7.1%
Adjusted beta1.011.29
Additional risk adjustments0.0%0.5%
Cost of equity8.8%12.9%
Tax rate12.6%13.8%
Debt/Equity ratio
0.880.88
Cost of debt5.0%5.0%
After-tax WACC6.7%8.9%
Selected WACC7.8%

300138.SZ's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 300138.SZ:

cost_of_equity (10.85%) = risk_free_rate (2.95%) + equity_risk_premium (6.60%) * adjusted_beta (1.01) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.